Center’s first White Paper on the Genomic Ecosystem of Serbia was published in June 2023, created in cooperation with the Ministry of Health and the Ministry of Science, Technological Development, and Innovation of the Government of the Republic of Serbia.
The publication is the result of analysis of the country’s genomic ecosystem, conducted by the C4IR Serbia team in the period from March to June 2022, overviewing the capacities for sequencing and the processing and application of genetic data in the Republic of Serbia. A series of surveys and interviews were conducted among academic and health workers as well as representatives of business companies, and total of 37 interlocutors from 16 organizations participated in the research.
To assess the existing capacities and the situation in the community, our team, together with its partners identified the main stakeholders and mapped available sequencing systems. This national inventory will enable progress to be monitored during the forthcoming year by means of a series of factors: increasing capacities and application of sequencing by high-throughput sequencing technologies, increased number of studies, improving the IT environment for genomics and other indicator.
The results of the analyzes represent the national overview presented in the publication, and in summary, the following was determined:
- In Serbia, a total of 13 organizations has equipment for high-throughput sequencing technologies
- A total of 21 second-, third- and fourth-generation systems are available manufactured by Illumina, BGI, PacBio and Oxford Nanopore
- The assessed current maximum sequencing capacity is 4493 whole human genomes annually
- The key missing component identified are IT resources for storage and processing of great data volumes
The White Paper can be found at the link HERE.
